Secure and Adaptable Ultrasound-Enhanced Ophthalmic Drug Delivery Systems for Niche Environments

Publication ID: 24-11857459_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Secure and Adaptable Ultrasound-Enhanced Ophthalmic Drug Delivery Systems for Niche Environments,” Published Technical Disclosure No. 24-11857459_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857459_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,459.

Summary of the Inventive Concept

This inventive concept adapts the original ultrasound-enhanced ophthalmic drug delivery system for specialized markets, focusing on high-security, extreme weather, disaster relief, extreme temperatures, and high-altitude environments. It integrates advanced encryption, weather-resistant designs, compact battery-powered devices, temperature-controlled components, and altitude-compensating software to address the unique challenges of these niche markets.

Background and Problem Solved

The original ultrasound-enhanced ophthalmic drug delivery system has limitations in adapting to specific, high-stakes environments. This inventive concept addresses these limitations by providing tailored solutions for secure, reliable, and efficient drug delivery in situations where conventional systems may fail or be compromised.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of specialized systems and methods for ultrasound-enhanced ophthalmic drug delivery. For high-security environments, the system incorporates advanced encryption and secure data transmission protocols in the ultrasound-generating device, ensuring the integrity of sensitive information. For extreme weather conditions, the system features a portable, weather-resistant ultrasound-generating device and a drug applicator with a weather-sealed design. In disaster relief situations, the system comprises a compact, battery-powered ultrasound-generating device and a drug applicator designed for rapid, single-use application. For extreme temperatures, the system includes an ultrasound-generating device with temperature-controlled components and a drug applicator with thermal insulation. Finally, for high-altitude environments, the system features an ultrasound-generating device with altitude-compensating software and a drug applicator designed for low-pressure operation. These adaptations enable the system to maintain its efficacy and reliability in challenging environments.

Novelty and Inventive Step

The inventive concept's novelty lies in its ability to adapt the original ultrasound-enhanced ophthalmic drug delivery system to specific, high-stakes environments. The inventive step is the integration of advanced encryption, weather-resistant designs, compact battery-powered devices, temperature-controlled components, and altitude-compensating software, which provides a new level of security, reliability, and efficiency in these niche markets.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different encryption protocols, varying weather-resistant materials, or alternative power sources for the ultrasound-generating device. Variations could also involve adapting the system for use in other specialized environments, such as space exploration or military operations.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the ophthalmic pharmaceutical industry, particularly in the areas of high-security facilities, disaster relief, and extreme environment operations. The market for these specialized systems is expected to grow as the need for secure and reliable drug delivery solutions increases in these niche environments.

CPC Classifications

SectionClassGroup
A A61 A61F9/0008
A A61 A61M37/0092
A A61 A61F2250/0093

Field of Art

Ophthalmic drug delivery systems, specifically ultrasound-enhanced transscleral drug application technologies, requiring expertise in medical device design, ultrasound physics, pharmaceutical delivery mechanisms, and environmental adaptation engineering

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device specialist with advanced degrees in bioengineering or medical technology, possessing knowledge of ultrasound technologies, drug delivery mechanisms, device miniaturization, and environmental engineering principles

Obviousness Rationale

A PHOSITA would recognize that adapting the ultrasound-enhanced drug delivery system to specialized environments represents predictable variations using known engineering techniques. The core technological principles of the source patent remain unchanged, with modifications representing standard design adaptations for different operational contexts. The PTD's variations demonstrate routine problem-solving within the established technological framework of ultrasound-enhanced drug delivery systems.

Obvious Combinations & Variations

Source Patent Element
Drug applicator configured for exchangeable and single-use application
PTD Variation
Compact, battery-powered device for disaster relief with rapid single-use drug applicator
Obviousness Reasoning
Extending single-use design concept to portable, emergency-focused configurations represents a predictable design variation addressing specific use-case requirements
Source Patent Element
Ultrasound transducer with signal generating unit and controller
PTD Variation
Ultrasound-generating device with encryption protocols and secure data transmission
Obviousness Reasoning
Integrating standard cybersecurity techniques into existing device architecture represents a known method of enhancing technological systems with minimal inventive complexity
Source Patent Element
Drug receiving space with surface coupling mechanisms
PTD Variation
Weather-sealed drug applicator design with thermal insulation for extreme environments
Obviousness Reasoning
Modifying surface coupling and material composition to withstand environmental challenges is a standard engineering approach for adapting medical devices to diverse operational conditions
Source Patent Element
Ultrasound coupling agent for eye drug delivery
PTD Variation
Altitude-compensating software and low-pressure operational design
Obviousness Reasoning
Implementing computational and mechanical adaptations to maintain device functionality across varying environmental conditions represents a predictable engineering solution
35 U.S.C. § 103 Summary: Based on US Patent 11857459's comprehensive disclosure of ultrasound-enhanced ophthalmic drug delivery systems, the present publication demonstrates that the claimed variations represent obvious extensions of existing technological principles, rendering subsequent claims involving similar environmental adaptations anticipated and non-patentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,459
TitleSystem and method for ultrasound-enhanced delivery of drugs
Assignee(s)SONIKURE HOLDINGS LIMITED